Famotidine and Hospitalized COVID-19 Patients: Are the Benefits True? | Am J Gastroenterol;116(7): 1561, 2021 07 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Famotidine and Hospitalized COVID-19 Patients: Are the Benefits True?

Amjad, Waseem; Malik, Adnan.

Amjad W; Department of Internal Medicine, Albany Medical Center, Albany, New York, USA.
Malik A; Hepatology, Loyola University Medical Center, Maywood, Illinois, USA.

Am J Gastroenterol ; 116(7): 1561, 2021 07 01.

Article in English | MEDLINE | ID: covidwho-1287014

Subject(s)

COVID-19; Famotidine; Famotidine/therapeutic use; Histamine H2 Antagonists; Humans; Retrospective Studies; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Famotidine / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: Am J Gastroenterol Year: 2021 Document Type: Article Affiliation country: Ajg.0000000000001217

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Famotidine / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: Am J Gastroenterol Year: 2021 Document Type: Article Affiliation country: Ajg.0000000000001217